Page last updated: 2024-08-21

alpha-aminopyridine and Metabolic Diseases

alpha-aminopyridine has been researched along with Metabolic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arner, EN; Brekken, RA; Cruz, VH; Scherer, PE; Wynne, KW1
Beno, DW; Liu, B; Liu, G; Liu, M; Lubbers, NL; Polakowski, JS; Serby, MD; Sham, HL; Trevillyan, JM; Widomski, DL; Xin, Z; Zhao, H1

Other Studies

2 other study(ies) available for alpha-aminopyridine and Metabolic Diseases

ArticleYear
Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
    Molecular metabolism, 2018, Volume: 16

    Topics: Aminopyridines; Animals; Body Weight; Diet, High-Fat; Disease Models, Animal; Fatty Liver; I-kappa B Kinase; Insulin; Insulin Resistance; Male; Metabolic Diseases; Mice; Mice, Inbred C57BL; Mice, Knockout; Obesity; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Weight Loss

2018
Hemodynamic effects of potent and selective JNK inhibitors in anesthetized rats: implication for targeting protein kinases in metabolic diseases.
    Bioorganic & medicinal chemistry letters, 2007, Jan-15, Volume: 17, Issue:2

    Topics: Aminopyridines; Anesthesia; Anesthetics; Animals; Blood Pressure; Enzyme Inhibitors; Heart Rate; Male; MAP Kinase Kinase 4; Metabolic Diseases; Myocardial Contraction; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiopental; Vascular Resistance; Ventricular Function, Left

2007